Get the Stockscreener App
3.72
19.61%
-0.93
Sensus Healthcare Inc stock is traded at $3.72, with a volume of 165.94K.
It is down -19.61% in the last 24 hours and down -29.47% over the past month.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
See More
Previous Close:
$4.65
Open:
$3.65
24h Volume:
165.94K
Relative Volume:
1.76
Market Cap:
$60.94M
Revenue:
$24.41M
Net Income/Loss:
$485.00K
P/E Ratio:
6.5263
EPS:
0.57
Net Cash Flow:
$-2.37M
1W Performance:
-25.83%
1M Performance:
-29.47%
6M Performance:
+9.30%
1Y Performance:
-32.03%
1-Day Range:
$3.55
$3.88
1-Week Range:
$3.55
$5.04
52-Week Range:
$3.03
$5.92
Sensus Healthcare Inc Stock (SRTS) Company Profile
Name
Sensus Healthcare Inc
Sector
Industry
Phone
561-922-5808
Address
851 BROKEN SOUND PARKWAY NW, BOCA RATON, FL
Compare SRTS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRTS
Sensus Healthcare Inc
|
3.71 | 76.38M | 24.41M | 485.00K | -2.37M | 0.57 |
|
ABT
Abbott Laboratories
|
112.09 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
372.89 | 140.01B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
101.31 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
75.16 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.90 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Sensus Healthcare Inc Stock (SRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-31-25 | Initiated | Lake Street | Buy |
| Nov-15-24 | Reiterated | Maxim Group | Buy |
| Feb-26-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Dec-16-20 | Downgrade | Northland Capital | Outperform → Market Perform |
| Aug-10-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Feb-14-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Nov-07-19 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jan-29-19 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-26-18 | Initiated | B. Riley FBR | Buy |
| Nov-03-17 | Reiterated | Maxim Group | Buy |
| Jun-06-17 | Initiated | Maxim Group | Buy |
| Aug-08-16 | Initiated | Northland Capital | Outperform |
View All
Sensus Healthcare Inc Stock (SRTS) Latest News
Sensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2025 Earnings Call Transcript - Insider Monkey
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Sensus Healthcare Inc (SRTS) Q4 2025 Earnings Call Highlights: N - GuruFocus
Sensus Healthcare Q4 Earnings Call Highlights - Yahoo Finance
Sensus Healthcare SRTS Q4 2025 Earnings Transcript - AOL.com
Earnings call transcript: Sensus Healthcare’s Q4 2025 earnings miss forecasts By Investing.com - Investing.com India
Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Estimates By $0.10 EPS - MarketBeat
Earnings call transcript: Sensus Healthcare’s Q4 2025 earnings miss forecasts - Investing.com
Sensus Healthcare (SRTS): Q4 Revenue Decline and 2026 Growth Pro - GuruFocus
SRTS: New CMS codes and strong cash position set the stage for growth and profitability in 2026 - TradingView
Sensus Healthcare (NASDAQ:SRTS) shareholders have endured a 36% loss from investing in the stock three years ago - Yahoo Finance
Preview: Sensus Healthcare's Earnings - Benzinga
Quarterly Recap: Is Sensus Healthcare Inc stock a good pick for beginners - baoquankhu1.vn
SRTS News Today | Why did Sensus Healthcare stock go down today? $SRTS - MarketBeat
Analysts Set Sensus Healthcare, Inc. (NASDAQ:SRTS) Target Price at $8.00 - Defense World
Quarterly Risk: Is Sensus Healthcare Inc stock risky to hold now2025 Price Momentum & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Lobbying Update: $15,000 of SENSUS HEALTHCARE INC. lobbying was just disclosed - Quiver Quantitative
Sensus Healthcare, Inc. (NASDAQ:SRTS) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Earnings call and business update from Sensus Healthcare set for Feb. 12 - Stock Titan
Analysis Recap: What are the future prospects of Sensus Healthcare Inc2025 Market Outlook & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Treatment Type Analysis - Market.us
ETF Watch: Can Sensus Healthcare Inc benefit from deglobalizationJuly 2025 Trends & Expert Approved Trade Ideas - baoquankhu1.vn
Global Medical Radiation Detection Devices Market to Increase at a Steady Growth Rate of ~7% by 2032 | DelveInsight - GlobeNewswire
Sensus Healthcare (SRTS) Expected to Announce Earnings on Wednesday - MarketBeat
Intraoperative Radiation Therapy Market Research Report - GlobeNewswire
3 Troubling Trends for Intuitive Surgical – and 1 Bright Spot - AOL.com
Larry Biscotti Joins Sensus Healthcare’s Board of Directors - Medical Product Outsourcing
Sensus Healthcare, Inc.'s (NASDAQ:SRTS) Price Is Right But Growth Is Lacking After Shares Rocket 38% - 富途牛牛
Sensus Healthcare appoints Carr, Riggs & Ingram as new auditor after acquisition - Investing.com
Sensus Healthcare (NASDAQ: SRTS) appoints Carr, Riggs & Ingram as new auditor - Stock Titan
Insider Sell: Will Red Violet Inc outperform small cap indexesQuarterly Performance Summary & Reliable Entry Point Trade Alerts - baoquankhu1.vn
VIX Spike: Can Sensus Healthcare Inc sustain earnings growthMarket Sentiment Review & Entry and Exit Point Strategies - baoquankhu1.vn
Sensus Healthcare (NASDAQ:SRTS) vs. Envoy Medical (NASDAQ:COCH) Financial Contrast - Defense World
Aug PreEarnings: Does SSYS outperform in volatile marketsWeekly Trade Review & AI Driven Stock Movement Reports - baoquankhu1.vn
Sensus Healthcare, Inc.'s (NASDAQ:SRTS) Share Price Boosted 38% But Its Business Prospects Need A Lift Too - Sahm
Travel Stocks: How does Sensus Healthcare Inc score in quality rankings2025 Trading Recap & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Insider Sell: Will Sensus Healthcare Inc stock maintain momentum in 2025Earnings Beat & High Conviction Trade Alerts - Bộ Nội Vụ
Geopolitics Watch: Is Sensus Healthcare Inc a top pick in the sectorQuarterly Portfolio Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
Dividend Watch: Does Sensus Healthcare Inc have strong EBITDA marginsEntry Point & Community Verified Swing Trade Signals - baoquankhu1.vn
Sensus Healthcare, Inc. (NASDAQ:SRTS) Given Average Recommendation of “Hold” by Analysts - Defense World
Sensus Healthcare, Inc. (NASDAQ:SRTS) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Tamar Securities Financial PortalSensus Healthcare, Inc.Common Stock (Nasdaq:SRTS) Stock Quote - FinancialContent
Why Sensus Healthcare Inc. stock remains a top recommendation2025 Analyst Calls & Daily Technical Stock Forecast Reports - Улправда
News | postregister.comSensus Healthcare, Inc.Common Stock (Nasdaq:SRTS) Detailed Stock Data - FinancialContent
Sensus Healthcare appoints GE HealthCare executive to board of directors By Investing.com - Investing.com Nigeria
Sensus Healthcare to Hold Investor Meetings During JPM Week 2026 in San Francisco - The Joplin Globe
Dental EconomicsSensus Healthcare to Hold Investor Meetings During JPM Week 2026 in San Francisco - FinancialContent
Sensus Healthcare, Inc. (SRTS) Dips More Than Broader Market: What You Should Know - MSN
Sensus Healthcare, Inc. Appoints Larry Biscotti as Director - marketscreener.com
Sensus Healthcare appoints GE HealthCare executive to board of directors - Investing.com
Sensus Healthcare Appoints Larry Biscotti to its Board of Directors - itemonline.com
Sensus Healthcare Inc Stock (SRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sensus Healthcare Inc Stock (SRTS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sachetta Eric | Director |
Nov 13 '25 |
Buy |
4.50 |
2,500 |
11,250 |
133,113 |
| Sardano Joseph C | CHIEF EXECUTIVE OFFICER |
Nov 18 '25 |
Buy |
4.03 |
25,000 |
100,750 |
1,200,293 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 18 '25 |
Buy |
3.80 |
1,000 |
3,800 |
118,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 11 '25 |
Buy |
4.26 |
1,000 |
4,260 |
117,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Aug 13 '25 |
Buy |
3.37 |
1,000 |
3,370 |
116,839 |
0.67%
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):